TMC-GCID Publications

Found 8 results
Filters: Author is Atmar, Robert L  [Clear All Filters]
2024
Lewis MA, Patil K, Ettayebi K, Estes MK, Atmar RL, Ramani S. Divergent responses of human intestinal organoid monolayers using commercial in vitro cytotoxicity assays. PLoS One. 2024 ;19(6):e0304526.
Ramani S, Cregeen SJJavornik, Surathu A, Neill FH, Muzny DM, Doddapaneni H, et al.. INTRA- AND INTER-HOST EVOLUTION OF HUMAN NOROVIRUS IN HEALTHY ADULTS. bioRxiv. 2024 ;.
2023
B Ayyar V, Ettayebi K, Salmen W, Karandikar UC, Neill FH, Tenge VR, et al.. CLIC and membrane wound repair pathways enable pandemic norovirus entry and infection. Nat Commun. 2023 ;14(1):1148.
Su L, Huang W, Neill FH, Estes MK, Atmar RL, Palzkill T. Mapping human norovirus antigens during infection reveals the breadth of the humoral immune response. NPJ Vaccines. 2023 ;8(1):87.
Lewis MA, Cortés-Penfield NW, Ettayebi K, Patil K, Kaur G, Neill FH, et al.. Standardization of an antiviral pipeline for human norovirus in human intestinal enteroids demonstrates nitazoxanide has no to weak antiviral activity. Antimicrob Agents Chemother. 2023 ;67(10):e0063623.
Lewis MA, Cortés-Penfield NW, Ettayebi K, Patil K, Kaur G, Neill FH, et al.. A Standardized Antiviral Pipeline for Human Norovirus in Human Intestinal Enteroids Demonstrates No Antiviral Activity of Nitazoxanide. bioRxiv. 2023 ;.
2021
Kondapi DSamantha, Ramani S, Estes MK, Atmar RL, Okhuysen PC. Norovirus in Cancer Patients: A Review. Open Forum Infect Dis. 2021 ;8(6):ofab126.
2020
Lin S-C, Qu L, Ettayebi K, Crawford SE, Blutt SE, Robertson MJ, et al.. Human norovirus exhibits strain-specific sensitivity to host interferon pathways in human intestinal enteroids. Proc Natl Acad Sci U S A. 2020 ;117(38):23782-23793.